Organ-on-chip (OoC) or micro-physiological systems (MPS) are innovative devices that emulate human/animal biology and can reproduce one or more aspects of an organ’s functionality. Among other benefits, they can lead to better testing of drugs and adapted treatments to genetic diversity, ethnicity, sex and age; reduce the cost of clinical trials and replace animal testing for cosmetic products, banned in Europe since 2013.
Since 2013, the European Commission’s Joint Research Centre (JRC) and the European standardisation organisations CEN and CENELEC have carried out annual joint ‘foresight on standardisation’ actions under the ‘Putting science into standards’ (PSIS) initiative. The PSIS initiative aims to facilitate the identification of emerging science and technology areas that could benefit from standardisation activities to enable innovation and promote industrial competitiveness.
Social media: #Standards4OoC
